Comments on: If You Can’t Beat ‘Em, Buy ‘Em. http://blog.pharmtech.com/2009/01/12/if-you-can%e2%80%99t-beat-%e2%80%98em-buy-%e2%80%98em/ The blog of Pharmaceutical Technology magazine Tue, 07 Feb 2012 17:25:13 -0500 http://wordpress.org/?v=2.8.4 hourly 1 By: Girish MALHOTRA http://blog.pharmtech.com/2009/01/12/if-you-can%e2%80%99t-beat-%e2%80%98em-buy-%e2%80%98em/comment-page-1/#comment-11797 Girish MALHOTRA Mon, 12 Jan 2009 22:14:58 +0000 http://blog.pharmtech.com/?p=760#comment-11797 Buying a "generic pharmaceutical" company is not the solution for R&D and manufacturing technology short comings. Innovation is. The attached links might be of interest. 1) http://pharmachemicalscoatings.blogspot.com/2008/12/is-creative-destruction-way-to-go-for.html 2) http://pharmachemicalscoatings.blogspot.com/2009/01/bail-out-or-hand-out-is-not-answer-but.html. 3) http://pharmachemicalscoatings.blogspot.com/2008/11/is-pharmaceutical-consolidation-on.html Pharmaceutical companies (Formulators of specialty chemicals (API) in dispensable form) have to think it through what they want to be 5-10 years down the road. My conjecture is that they will be some form of Novartis but will have better technologies. Effort would be needed to get there. Buying a “generic pharmaceutical” company is not the solution for R&D and manufacturing technology short comings. Innovation is. The attached links might be of interest.

1) http://pharmachemicalscoatings.blogspot.com/2008/12/is-creative-destruction-way-to-go-for.html

2) http://pharmachemicalscoatings.blogspot.com/2009/01/bail-out-or-hand-out-is-not-answer-but.html.

3) http://pharmachemicalscoatings.blogspot.com/2008/11/is-pharmaceutical-consolidation-on.html

Pharmaceutical companies (Formulators of specialty chemicals (API) in dispensable form) have to think it through what they want to be 5-10 years down the road. My conjecture is that they will be some form of Novartis but will have better technologies. Effort would be needed to get there.

]]>